Prospects for therapy and prophylaxis of adenovirus keratoconjunctivitis;Perspektiven von therapie und prophylaxe der adenoviruskeratokonjunktivitis

Ophthalmologe

Volumn 98, Issue 10, 2001, Pages 991-1009

  Sundmacher, R ^a   Hillenkamp, J ^a   Reinhard, T ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CYCLOSPORIN A; STEROID;

ADENOVIRUS; CLINICAL FEATURE; HUMAN; IMMUNOMODULATION; KERATOCONJUNCTIVITIS; PERSISTENT VIRUS INFECTION; PROPHYLAXIS; RETINITIS; REVIEW;

EID: 0034783235     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470170052     Document Type: Review

References (81)

1. Ciclosporin A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatographyelectrospray mass spectrometry
2. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis
3. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′nor-cyclic GMP on adenovirus replication in vitro
4. Cyclosporin eye drops for the treatment of severe vernal keratoconjunctivitis
5. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation
6. Epidemic keratoconjunctivitis in a chronic care facility: Risk factors and measures for control
7. Inflammation related scarring after photorefractive keratectomy
8. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 Kidneys, 2 pancreases and 2 livers
9. Epidemic keratoconjunctivitis caused by a new genotype of adenovirus type 8 (ad8) - A chronological review of ad8 in southern Taiwan
10. Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London
11. Follicular conjunctivitis
12. Therapeutic potential of HPMPC as an antiviral drug
13. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation
14. Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates
15. Epidemiology of epidemic keratoconjunctivitis
16. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis A preliminary report
17. Keratitis punctata superficialis
18. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication
19. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro
20. Treatment of adenoviral conjunctivitis with topical cidofovir
21. An ocular model of adenovirus type 5 infection in the NZ rabbit
22. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model
23. Pretreatment with topical 0,1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model
24. Inhibitory effect of (S)-HPMPC, (s)-SPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro
25. Surveillance and control of epidemic keratoconjunctivitis
26. Pathologisch-anatomischer befund einer hornhaut bei keratitis epidemica
27. Topical treatment of acute adenoviral keratoconjunctivitis with Cidofovir 0.2% and Ciclosporin A 1%. A controlled clinical pilot study
28. Topical treatment of acute adenoviral keratoconjunctivitis with Cidofovir 1%. A controlled clinical pilot study
29. Topical cyclosporin A in the treatment of anterior segment inflammatory disease
30. Masked trial of topical cyclosporine A in the treatment of refractory Thygeson's punctate keratitis
31. Keratokonjunktivitis epidemica: Therapieergebnisse während einer epidemie
32. New type of APC virus from epidemic keratoconjunctivitis
33. Keratoconjunctivitis associated with adenovirus type 37: An extended outbreak in an ophthalmologist's office
34. Use of polymerase chain reaction for the detection of adenovirus in ocular swab specimens
35. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments
36. Ocular adenoviral infections
37. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children
38. Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis
39. Corneal histology after epidemic keratoconjunctivitis
40. In vitro effects of antiviral agents on human keratocytes
41. Selective inhibition of human cytomegalie DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine (HPMPC)
42. Late onset of haze associated with viral keratoconjunctivitis following photorefractive keratectomy
43. Phototherapeutische Keratektomie (PTK) nach keratokonjunktivitis epidemica
44. Distribution of integrins alpha v beta 5, alpha v beta 3 and alpha v in normal human cornea: Possible implications in clinical and therapeutic adenoviral infection
45. Adenovirus type 8 keratoconjunctivitis - An outbreak and its tretment with topical human fibroblast interferon
46. Lokales cyclosporin A bei nummuli nach keratokonjunktivitis epidemica. Eine pilotstudie
47. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A
48. Perforierende keratoplastik bei endogenem ekzem, eine indikation für cyclosporin A systemisch - Eine retrospektive studie über 18 patienten
49. Lokale Ciylosporin A therapie bei keratitis superficialis punctata Thygeson - Eine pilotstudie
50. Lokale cyclosporin-A-therapie bei nummuli nach keratokonjunktivitis epidemica - Fallbericht
51. Topical cyclosporin A in Thygeson's superficial punctate keratitis
52. Systemic cyclosporin A in high-risk keratoplasties
53. Adenoviral ocular isolates demonstrate serotype-dependent differences in in-vitro infectivity titers and clinical course
54. Use of human fibroblastderived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis
55. Ten years of experience with human fibroblast interferon in treatment of viral ophthalmic infections
56. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model
57. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model
58. The effects of corticosteroids on adenoviral replication
59. Lokale interferon-prophylaxe einer "epidemischen" konjunktivitis durch ein bislang nicht identifizierbares virus
60. Systemische Cycloporin A prophylaxe bei risiko-keratoplastiken
61. A randomized double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis
62. Ulkus mooren vier schwere beidseitige verläufe unter systemischer ciclosporin-A-therapie
63. Adeno-viral keratoconjunctivitis
64. Interferon in ocular viral diseases
65. Zum problem der rezidivierenden und persistierenden nummuli nach keratokonjunktivitis epidemica
66. Cyclosporin A systemisch nach keratoplastik wegen rheumatischer hornhautperforation und bei essentieller bindehautschrumpfung
67. Six years' experience with sytemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients
68. The value of exogenous interferon in adenovirus keratoconjunctivitis. Preliminary results
69. Efficacy of a disinfectant wipe method for the removal of adenovirus 8 from tonometer tips
70. Die wirkung von steroiden bei keratoconjunctivitis epidemica. Ergebnisse einer kontrollierten prospektiven studie
71. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes
72. An experimental animal model of adenovirus-induced ocular disease. The cotton rat
73. Acute follicular conjunctivitis caused by adenovirus type 34
74. Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1
75. Inhibition of herpes simplex virus production in vitro by Cyclosporin A
76. A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis
77. A large outbreak of epidemic keratoconjunctivitis: Problems in controlling nosocomial spread
78. A 5-year evaluation of the adenoclone test for the rapid diagnosis of adenovirus from conjunctival swabs
79. Topical human fibroblast interferon for acute adenoviral conjunctivitis
80. Immunological analysis and treatment of Mooren's ulcer with cyclosporine A applied topically